Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jan;69(1):166-71.
doi: 10.1128/JVI.69.1.166-171.1995.

Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein

Affiliations

Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein

D Brand et al. J Virol. 1995 Jan.

Abstract

Various roles for the viral receptor, CD4, have been proposed in facilitating human immunodeficiency virus type 1 (HIV-1) entry, including virion binding to the target cell and the induction of conformational changes in the viral envelope glycoproteins required for the membrane fusion reaction. Here, we compare the structural requirements in the CDR2-like loop of CD4 domain 1, the major contact site of the gp120 envelope glycoprotein, for gp120 binding and virus entry. For every CD4 mutant examined, the level of cell surface expression and the gp120 binding affinity were sufficient to explain the relative ability to function as a viral receptor. The decrease in relative infectibility associated with decreased gp120 binding affinity was more pronounced at lower cell surface CD4 concentrations. These results imply that both receptor density and affinity determine the efficiency of HIV-1 entry and that specific structures in the CD4 residues examined are probably not required for HIV-1 entry functions other than gp120 binding.

PubMed Disclaimer

References

    1. Science. 1983 May 20;220(4599):868-71 - PubMed
    1. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93 - PubMed
    1. Science. 1984 May 4;224(4648):500-3 - PubMed
    1. Nature. 1984 Nov 8-14;312(5990):159-62 - PubMed
    1. Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 - PubMed

Publication types